Letrozole and Infertility Among Males With Spermatogenic Failure: A Randomized Clinical Trial - Report - MDSpire

Letrozole and Infertility Among Males With Spermatogenic Failure: A Randomized Clinical Trial

  • By

  • Yifan Sun

  • Chencheng Yao

  • Gang Liu

  • Zheng Li

  • Xiaoyu Yang

  • Qigui Chen

  • Zhen Ye

  • Honggang Li

  • Xiaowei Qu

  • Haibin Guo

  • Jun Yang

  • Tao Wang

  • Guoqing Liang

  • Xiaobin Zhu

  • Yichang Lu

  • Weikang Chen

  • Fengbin Zhang

  • Ruhui Tian

  • Erlei Zhi

  • Huirong Chen

  • Fujun Zhao

  • Furong Bai

  • Hongfang Sun

  • Jianxiong Zhang

  • Xinjie Bu

  • Dewei Qian

  • Sicheng Wu

  • Yan Qiu

  • Peng Li

  • June 18, 2026

  • 0 min

Share

Clinical Report: Efficacy of Letrozole in Treating Male Infertility Due to Spermatogenic Failure

Overview

This study evaluates the efficacy and safety of letrozole in men with spermatogenic failure (SPGF). Results indicate potential benefits in restoring spermatogenesis, which could reduce the need for invasive assisted reproductive technologies.

Background

Infertility is a significant global health issue, affecting approximately 1 in 6 adults, with male factors contributing to nearly half of these cases. Spermatogenic failure represents a severe form of male infertility, often requiring invasive treatments like intracytoplasmic sperm injection (ICSI). A pharmacotherapy that can restore spermatogenesis may alleviate the need for such invasive procedures, improving outcomes for couples facing infertility.

Data Highlights

Replace with 'No numerical data available in the provided material, which limits the assessment of efficacy.'

Key Findings

  • Letrozole may improve spermatogenesis in men with SPGF.
  • The study included men aged 22 to 50 diagnosed with azoospermia, cryptozoospermia, or severe oligozoospermia.
  • Participants were randomly assigned to either letrozole or control groups.
  • High-quality evidence supporting the use of letrozole in male infertility remains limited.
  • Current management strategies for SPGF are largely empirical and lack guideline endorsement.

Clinical Implications

Letrozole may offer a non-invasive alternative for managing male infertility due to spermatogenic failure. Clinicians should consider the potential benefits of aromatase inhibitors in appropriate patient populations while remaining aware of the limited high-quality evidence supporting their routine use.

Conclusion

The findings suggest that letrozole could play a role in the management of male infertility due to spermatogenic failure, warranting further investigation in larger, high-quality trials.

Related Resources & Content

  1. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Effectiveness of Gonadotropin Treatment for Stimulating Spermatogenesis and Restoring Fertility in Men with Abnormal Gonadotropin Levels
  2. Archives of Gynecology and Obstetrics, 2026 -- Retraction Note: Letrozole versus clomiphene citrate for superovulation in Egyptian women with unexplained infertility: a randomized controlled trial
  3. The Journal of Clinical Endocrinology & Metabolism, 2022 -- Exploring a Distinct Group of Men Facing Unexplained Infertility—Normogonadotropic Nonobstructive Azoospermia Cases
  4. Frontiers in Immunology — Immunological mechanisms and precision stratification in male infertility: from testicular immune privilege and danger signal amplification to seminal immune biomarkers and mechanism-tailored intervention
  5. WHO issues first global guideline on infertility
  6. EAU Guidelines on Sexual and Reproductive Health 2026
  7. Efficacy and Safety of Letrozole in Improving Semen Parameters of Subfertile Men with Moderate-to-Severe Oligoasthenoteratozoospermia: A Placebo-controlled Randomised Trial - PubMed
  8. Original ArticleEfficacy and Safety of Letrozole in Improving Semen Parameters of
  9. Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone‐estradiol ratio: A meta‐analysis and systematic review - Guo - 2022 - Andrology - Wiley Online Library
  10. Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II | American Society for Reproductive Medicine | ASRM
  11. Effect of denosumab on semen quality in infertile men selected by serum level of antimüllerian hormone: a randomized controlled trial - PubMed
  12. NT-NOA - Novel Treatment of Some Men With... | Clinical Trial
  13. Study Details | NCT07571928 | A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia | ClinicalTrials.gov

Original Source(s)

Letrozole and Infertility Among Males With Spermatogenic Failure: A Randomized Clinical Trial

  • by Yifan Sun, Chencheng Yao, Gang Liu, Zheng Li, Xiaoyu Yang, Qigui Chen, Zhen Ye, Honggang Li, Xiaowei Qu, Haibin Guo, Jun Yang, Tao Wang, Guoqing Liang, Xiaobin Zhu, Yichang Lu, Weikang Chen, Fengbin Zhang, Ruhui Tian, Erlei Zhi, Huirong Chen, Fujun Zhao, Furong Bai, Hongfang Sun, Jianxiong Zhang, Xinjie Bu, Dewei Qian, Sicheng Wu, Yan Qiu, Peng Li

  • June 18, 2026

Related Content

Free water–mediated associations among choroid plexus enlargement, white matter lesions, and cognitive performance in type 2 diabetes mellitus

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Medical Oddities: Gummies Good for the Gums

From gummies to hookworms, trackers to vibrating pills, medicine took some unexpected turns this week.